Andrew G. Geiser
Lilly Research Laboratories
Eli Lilly & Co.
Lilly Corporate Center
Indianapolis
USA
Name/email consistency: high
- A new selective estrogen receptor modulator with potent uterine antagonist activity, agonist activity in bone, and minimal ovarian stimulation. Geiser, A.G., Hummel, C.W., Draper, M.W., Henck, J.W., Cohen, I.R., Rudmann, D.G., Donnelly, K.B., Adrian, M.D., Shepherd, T.A., Wallace, O.B., McCann, D.J., Oldham, S.W., Bryant, H.U., Sato, M., Dodge, J.A. Endocrinology (2005)
- Decreased bone mass and bone elasticity in mice lacking the transforming growth factor-beta1 gene. Geiser, A.G., Zeng, Q.Q., Sato, M., Helvering, L.M., Hirano, T., Turner, C.H. Bone (1998)